Drug and Alcohol Dependence
Volume 107, Issue 2 , Pages 161-170 , 1 March 2010

Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes

  • Lori L. Davis

      Affiliations

    • VA Medical Center, 3701 Loop Road E., Tuscaloosa, AL 35404, United States
    • University of Alabama at Birmingham, Birmingham, AL 35294, United States
    • Corresponding Author InformationCorresponding author at: VA Medical Center (151), 3701 Loop Road East, Tuscaloosa, AL 35404, United States. Tel.: +1 205 554 2000; fax: +1 205 554 2877.
    • ,
  • Stephen R. Wisniewski

      Affiliations

    • University of Pittsburgh, Epidemiology Data Center, 130 DeSoto Street, 127 Parran Hall Pittsburgh, PA 15261, United States
    • ,
  • Robert H. Howland

      Affiliations

    • University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, 3811 O’Hara Street #430, Pittsburgh, PA 15213, United States
    • ,
  • Madhukar H. Trivedi

      Affiliations

    • University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390, United States
    • ,
  • Mustafa M. Husain

      Affiliations

    • University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390, United States
    • ,
  • Maurizio Fava

      Affiliations

    • Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States
    • ,
  • Patrick J. McGrath

      Affiliations

    • Columbia University and New York State Psychiatric Institute, 180 Ft. Washington Ave., New York, NY 10032, United States
    • ,
  • G.K. Balasubramani

      Affiliations

    • University of Pittsburgh, Epidemiology Data Center, 130 DeSoto Street, 127 Parran Hall Pittsburgh, PA 15261, United States
    • ,
  • Diane Warden

      Affiliations

    • University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390, United States
    • ,
  • A. John Rush

      Affiliations

    • Duke-National University of Singapore, 8 College Road, Singapore 169857, Singapore

Received 13 March 2009 ,Revised 7 October 2009 ,Accepted 12 October 2009.

References 

  1. Abraham HD, Fava M. Order of onset of substance abuse and depression in a sample of depressed outpatients. Comp. Psychiatry. 1999;40:44–50
  2. Agosti V, Levin FR. The effects of alcohol and drug dependence on the course of depression. Am. J. Addict. 2006;15:71–75
  3. Cami J, Farre M. Drug addiction. N. Engl. J. Med. 2003;349:975–986
  4. Compton WM, Cottler LB, Ben AA, Phelps DL, Spitznagel EL, Horton JC. Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. Am. J. Addict. 2000;9:113–125
  5. Cornelius JR, Clark DB, Bukstein OG, Birmaher B, Salloum IM, Brown SA. Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review. Addict. Behav. 2005;30:1824–1833
  6. Davis LL, Rush AJ, Wisniewski SR, Rice K, Cassano P, Jewell ME, et al. Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the sequenced treatment alternatives to relieve depression cohort. Comp. Psychiatry. 2005;46:81–89
  7. Davis LL, Frazier E, Husain MM, Warden D, Trivedi M, Fava M, et al. Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort. Am. J. Addict. 2006;15:278–285
  8. Fava M, Abraham M, Alpert J, Nierenberg AA, Pava JA, Rosenbaum JF. Gender differences in Axis I comorbidity among depressed outpatients. J. Affect. Disord. 1996;38:129–133
  9. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr. Clin. North Am. 2003;26:457–494
  10. Ford JD, Gelernter J, DeVoe JS, Zhang W, Weiss RD, Brady K, et al. Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals. Drug Alcohol Depend. 2009;99:193–203
  11. Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend. 1995;39:197–206
  12. Grant BF. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J. Subst. Abuse. 1995;7:481–497
  13. Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello LR, et al. The effect of depression on return to drinking: a prospective study. Arch. Gen. Psychiatry. 1998;55:259–265
  14. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  15. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967;6:278–296
  16. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch. Gen. Psychiatry. 2002;59:375–380
  17. Hasin DS, Grant BF. Major depression in 6050 former drinkers: association with past alcohol dependence. Arch. Gen. Psychiatry. 2002;59:794–800
  18. Howland RH, Rush AJ, Wisniewski SR, Trivedi MH, Warden D, Fava M, et al. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug Alcohol Depend. 2009;99:248–260
  19. Kay-Lambkin FJ, Baker A, Carr VJ. Depression and drug and alcohol problems. In:  Baker A,  Velleman R editor. Clinical Handbook of Coexisting Mental Health and Drug and Alcohol Problems. New York, NY: Routledge/Taylor & Francis Group; 2007;p. 218–240
  20. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–3105
  21. Kosten TR, O’Connor PG. Management of drug and alcohol withdrawal. N. Engl. J. Med. 2003;348:1786–1795
  22. Lin N, Eisen SA, Scherrer JF, Jin R, Koretz D, Merikangas KR, et al. The influence of familial and non-familial factors on the association between major depression and substance abuse/dependence in 1874 monozygotic male twin pairs. Drug Alcohol Depend. 1996;43:49–55
  23. Lukassen J, Beaudet MP. Alcohol dependence and depression among heavy drinkers in Canada. Soc. Sci. Med. 2005;61:1658–1667
  24. Lyons MJ, Schultz M, Neale M, Brady K, Eisen S, Toomey R, et al. Specificity of familial vulnerability for alcoholism versus major depression in men. J. Nerv. Ment. Dis. 2006;194:809–817
  25. Magruder KM, Sonne SC, Brady KT, Quello S, Martin RH. Screening for co-occurring mental disorders in drug treatment populations. J. Drug Issues. 2005;35:593–605
  26. McDermut W, Mattia J, Zimmerman M. Comorbidity burden and its impact on psychosocial morbidity in depressed outpatients. J. Affect. Disord. 2001;65:289–295
  27. McDowell D, Nunes EV, Seracini AM, Rothenberg J, Vosburg SK, Ma GJ, et al. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. Drug Alcohol Depend. 2005;80:209–221
  28. McKay JR. Co-occurring substance dependence and depression: practical implications and next questions. Addiction. 2005;100:1755–1757
  29. Melartin TK, Rytsala HJ, Leskela US, Lestela-Mielonen PS, Sokero TP, Isometsa ET. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J. Clin. Psychiatry. 2002;63:126–134
  30. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA. 2004;291:1887–1896
  31. Nurnberger JI, Foroud T, Flury L, Su J, Meyer ET, Hu K, et al. Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. Am. J. Psychiatry. 2001;158:718–724
  32. Oslin DW, Katz IR, Edell WS, Ten Have TR. Effects of alcohol consumption on the treatment of depression among elderly patients. Am. J. Geriatr. Psychiatry. 2000;8:215–220
  33. Oslin DW. Treatment of late-life depression complicated by alcohol dependence. Am. J. Geriatr. Psychiatry. 2005;13:491–500
  34. Ostacher MJ. Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment. Psychiatr. Clin. North Am. 2007;30:69–76
  35. Partonen T, Sihvo S, Lonnqvist JK. Patients excluded from an antidepressant efficacy trial. J. Clin. Psychiatry. 1996;57:572–575
  36. Pettinati HM. Antidepressant treatment of co-occurring depression and alcohol dependence. Biol. Psychiatry. 2004;56:785–792
  37. Rae AM, Joyce PR, Luty SE, Mulder RT. The effect of a history of alcohol dependence in adult major depression. J. Affect. Disord. 2002;70:281–290
  38. Ramsey SE, Engler PA, Stein MD. Alcohol use among depressed patients: the need for assessment and intervention. Prof. Psychol. Res. Pract. 2005;36:203–207
  39. In:  Robins LN,  Regier DA editor. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: The Free Press; 1991;
  40. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol. Med. 1996;26:477–486
  41. Rush AJ, Carmody TJ, Reimitz PE. The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int. J. Methods Psychiatr. Res. 2000;9:45–59
  42. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol. Psychiatry. 2003;54:573–583Erratum p. 585
  43. Rush, A.J., Fava, M., Wisniewski, S.R., Lavori, P.W., Trivedi, M.H., Sackeim, H.A., Thase, M.E., Nierenberg, A.A., Quitkin, F.M., Kashner, T.M., Kupfer, D.J., Rosenbaum, J.F., Alpert, J., Stewart, J.W., McGrath, P.J., Biggs, M.M., Shores-Wilson, K., Lebowitz, B.D., Ritz, L., Niederehe, G. STAR*D Investigators Group, 2004. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Control. Clin. Trials 25, 119–142. www.star-d.org (accessed September 7, 2009).
  44. Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D, et al. Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J. Affect. Disord. 2005;87:43–55
  45. Salloum IM, Mezzich JE, Cornelius J, Day NL, Daley D, Kirisci L. Clinical profile of comorbid major depression and alcohol use disorders in an initial psychiatric evaluation. Comp. Psychiatry. 1995;36:260–266
  46. Sanderson WC, Beck AT, Beck J. Syndrome comorbidity in patients with major depression or dysthymia: prevalence and temporal relationships. Am. J. Psychiatry. 1990;147:1025–1028
  47. Sher L. Serotonin and suicidal behavior in patients with comorbid depression and alcoholism. Am. J. Addict. 2006;15:198
  48. Sher L, Oquendo MA, Grunebaum MF, Burke AK, Huang YY, Mann JJ. CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence. Eur. Neuropsychopharmacol. 2007;17:12–15
  49. Sher L, Stanley BH, Harkavy-Friedman JM, Carballo JJ, Arendt M, Brent DA, et al. Depressed patients with co-occurring alcohol use disorders: a unique patient population. J. Clin. Psychiatry. 2008;69:907–915
  50. Sullivan LE, Fiellin DA, O’Connor PG. The prevalence and impact of alcohol problems in major depression: a systematic review. Am. J. Med. 2005;118:330–341
  51. Thase ME, Salloum IM, Cornelius JD. Comorbid alcoholism and depression: treatment issues. J. Clin. Psychiatry. 2001;62:32–41
  52. Torrens M, Fonseca F, Mateu G, Farré M. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug Alcohol Depend. 2005;78:1–22
  53. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol. Med. 2004;34:73–82
  54. Watkins KE, Paddock SM, Zhang L, Wells KB. Improving care for depression in patients with comorbid substance misuse. Am. J. Psychiatry. 2006;163:125–132
  55. Westermeyer J, Eames SL, Nugent S. Comorbid dysthymia and substance disorder: treatment history and cost. Am. J. Psychiatry. 1998;155:1556–1560
  56. Wines JD, Saitz R, Horton NJ, Lloyd-Travaglini C, Samet JH. Suicidal behavior, drug use and depressive symptoms after detoxification: a 2-year prospective study. Drug Alcohol Depend. 2004;7:S21–S29
  57. Zimmerman M, Mattia JI. A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch. Gen. Psychiatry. 2001;58:787–794
  58. Zimmerman M, Mattia JI. The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Comp. Psychiatry. 2001;42:175–189
  59. Zimmerman M, Chelminski I, McDermut W. Major depressive disorder and axis I diagnostic comorbidity. J. Clin. Psychiatry. 2002;63:187–193

PII: S0376-8716(09)00391-3

doi: 10.1016/j.drugalcdep.2009.10.003

Drug and Alcohol Dependence
Volume 107, Issue 2 , Pages 161-170 , 1 March 2010

Article Tools

* Image Usage & Resolution